Form D · Other Health Care
Hyka Therapeutics Inc.
Somerville, MA · CIK 0001879207
Offering snapshot reported Sep 20, 2021 · SEC filing
- Reported sold
- $307K Offering amount: $750K
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 20, 2021 | Initial | $307,150 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-413945
Source: Form D, filed Sep 20, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeronimo Beccar | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
13 Bolton Street
Somerville, MA, 02413
Somerville, MA, 02413